MedPath

Assesment for Response to Candesartan in Diabetic Nephropathy

Not Applicable
Conditions
Hypertensive patients with diabetic nephropathy
Registration Number
JPRN-UMIN000000497
Lead Sponsor
niversity of Tokyo Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

1. Severe hypertension: 180/110 mmHg or above. 2. Severe cardiovascular conplication 3. Severe diabetes 4. Pregnancy 5. History of severe side effect of ARB or ACE inhibitor 6. Patients who are treating with ARB or ACE inhibitor 7. Patients who are inadequate to enty this study by physisicans in charge.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath